Monthly Prescribing Reference3 天
NIH Study IDs Potential Treatment Strategy for Kids With High-Threshold Peanut Allergy
The phase 2 CAFETERIA study included participants aged 4 to 14 years who were able to tolerate at least 143mg of peanut protein.